Global /China /Healthcare /Biotechnology /688098

Shanghai Shen Lian Biomedical Corp.

688098

• SSE: 688098 • Delayed

8.84CNY -1%

1.31 USD

As of 15 June 2026, Shanghai Shen Lian Biomedical Corp. has a market cap of $541.87M USD, ranking #14611 globally and #4532 in China. It ranks #1300 in the Healthcare sector, and #243 in the Biotechnology industry.

Global Rank

14611

Country Rank

4532

Sector Rank

1300

Industry Rank

243

Key Stats

Market Cap

$541.87MUSD

3.67B CNY

Enterprise Value

$522.54MUSD

3.54B CNY

Revenue (TTM)

$42.6MUSD

288.27M CNY

EBITDA (TTM)

$8.98MUSD

60.79M CNY

Net Income (TTM)

-$3.03MUSD

-20.5M CNY

EBITDA Margin

21%

Profit Margin

-7.1%

PS Ratio

12.7

PB Ratio

2.6

EV/EBITDA

57.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Zhen Zhang open_in_new

Employees

374

Founded

2001

Website

slbio.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1%	3.3%	2.8%	-5.9%	-15%	-0.5%	62%	15%	-31%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688098 申联生物医药(上海)股份有限公司 Class A ISIN: CNE100003P17 Shares Out.: Shares Outstanding: 407.227M¹ Shares Float: 407.196M² TV: TradingView: SSE: 688098 SA: Stock Analysis: SHA: 688098 YF: Yahoo Finance: 688098.SS GF: Google Finance: SHA: 688098 BA: Barron's: 688098 MS: Morningstar: XSHG: 688098	8.84 CNY	TV: TradingView: SSE: 688098 SA: Stock Analysis: SHA: 688098 YF: Yahoo Finance: 688098.SS GF: Google Finance: SHA: 688098 BA: Barron's: 688098 MS: Morningstar: XSHG: 688098

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shanghai Shen Lian Biomedical Corp.

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.45B 136.71B HKD 3K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 2K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.01B 54.23B CNY 1K%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.34B 49.69B CNY 1K%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 1K%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.73B 45.52B CNY 1K%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 34K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 29K%	19.0	United States
argenx SE EBR: ARGX	$47.89B 41.39B EUR 9K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.92B 68.19T KRW 8K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.46B 60.27B AUD 8K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.17B 33.71B CHF 8K%	37.2	Switzerland

chevron_leftBack